With $43M haul, Atlas-backed startup applies precision medicine to eye disease
October 17, 2017 at 07:00 AM EDT
Cambridge-based Gemini Therapeutics is using a "precision medicine" approach being used increasingly among cancer drug developers, but which is new in the field of ophthalmology.
